Main Products:
Disinfectant, Hemodialysis Machine Disinfectant, Skin Disinfectant Solution, Mucous Membrane Disinfectant Solution, Hand Hygiene, Medical Instrument Disinfectant Solution, Antibacterial / Antimicrobial Preparation, Environmental Surface Disinfection, Medical Cleaning Agent / Medical Detergent, Wet Wipes & Tissue
Company Profile:
Founded in 2011, Shandong Disineer is a leading national high-tech enterprise in China's medical infection control sector. Integrating R&D, manufacturing, sales, and service, it safeguards the nation's healthcare system through proprietary products and integrated solutions. Headquartered in Dezhou, Shandong, Disineer operates a self-owned manufacturing base covering over 80, 000 sqm, with dual R&D centers in Shanghai and Shandong. With strong export capability, Disineer s products serve customers worldwide. Committed to medical infection control, the Company has forged a dual-engine structure encompassing disinfection products and medical devices. Its portfolio features over 100 products across ten major series-including environmental surface and skin/mucous membrane disinfection-spanning Class I, II, and III medical devices for healthcare, public health, industrial, and commercial settings. As a core strategic line, the Endoscopy Center System Solution addresses pain points in standardized cleaning, disinfection, and closed-loop management, combining core hardware (automated endoscope reprocessors, cleaning workstations, storage units) with specialized consumables (peracetic acid disinfectants, enzymatic detergents). Through independent R&D and in-house manufacturing across the chain, Disineer provides integrated, one-stop, standardized solutions. Adhering to a "technology-driven development" strategy, Disineer operates a dual-engine R&D framework anchored by Shanghai and Shandong centers. The innovation pipeline is LED by Technical Director Professor Yuan Chaosen, former Editor-in-Chief of the Chinese Journal of Disinfection. The Company engages top experts as advisors, including Professor Wang Zhiqian of Beijing University of Chemical Technology. Through industry-university-research platforms and post-doctoral workstations with Beijing University of Chemical Technology and Jiangnan University, Disineer has built an end-to-end innovation ecosystem centered on commercialization of scientific achievements. To date, Disineer holds over 50 authorized patents (including 26 invention patents), multiple Class II and III medical device registrations, and has co-authored nearly 20 national, industry, and group standards. Accredited as a National High-Tech Enterprise for four consecutive terms, it has earned Shandong provincial honors including Single Champion in Manufacturing, Hidden Champion, Gazelle Enterprise, Specialized and Innovative Enterprise, and Quality Benchmark. Its R&D Center is recognized as a Shandong Provincial Enterprise Technology Center, and the Company serves on the National Health Commission's Disinfection Standards Committee. With a nationwide sales and service network, Disineer partners with over 3, 000 graded hospitals (including 800+ Grade A tertiary facilities) and thousands of primary healthcare institutions. It also collaborates with major state-level organizations including the Civil Aviation Administration, China State Railway Group, and China National Petroleum Corporation, extending its footprint across aviation, railway, public environment, and industrial sectors. As a veteran-founded enterprise, Disineer embodies military values of loyalty and responsibility, fulfilling social commitment through education sponsorship, academic support, and public health emergency response. It has donated over 10 million RMB in supplies to public welfare. Designated a key national epidemic prevention supplier, Disineer stepped forward during the Wuhan outbreak and Henan 7·20 floods to deliver disinfection materials to front lines. Standing at a new milestone, Disineer remains committed to its ethos of "relentless self-improvement and actions over words" and its mission to build a robust infection control defense for China's healthcare system. It will leverage technological innovation to establish a national benchmark brand in medical infection control, contributing to the Healthy China initiative.
